A simple blood draw enables sensitive detection of blood cancers, such as acute myeloid leukemia and myeloproliferative neoplasms, in addition to melanoma, lung, colorectal, and pancreatic cancers, through analysis of actionable mutations in circulating tumor DNA. (sciencemag.org)
«These data highlight the adoption of mutation testing by the lung cancer community and demonstrate the utility of a centralized laboratory for the evaluation of actionable mutations from blood,» commented first author Hestia Mellert, PhD, Director of Molecular Development at Biodesix, Inc. «Physicians in remote locations may now have greater and more rapid access to this critical patient information.» (sciencedaily.com)
«It represents a model of collaboration between cancer centers, represents a monumental operational, technical and computational achievement and finally represents the value of precision medicine in finding actionable mutations.» (sciencedaily.com)